Articles From: Ameren Executives to Present at Wolfe Research Power & Gas Leaders Conference on Sept. 18, 2014 to BioTime Subsidiary, Asterias Biotherapeutics, and Cancer Research UK and Cancer Research Technology Partner for Clinical Trial of Immunotherapy Vaccine for Lung Cancer


PITTSBURGH , Sept.
Sign-up for ANSYS Listed On Software 500 For Eighth Consecutive Year investment picks
ORLANDO, Fla.
Sign-up for API Technologies Announces Third Quarter Earnings Call investment picks
2014/9/11
Following the Apple Announcement, Survey Finds Only One in Ten College and High School Students Plan to Purchase the Apple Watch, While One Third Plan to Purchase the New iPhone SANTA CLARA, Calif.
Sign-up for Apple Losing its Cool: With iPhone 6, Chegg Survey Finds College Students Rate Apple Less "Cool" Than Tech Giant Counterparts investment picks
By Li Xiaoxiao BEIJING (Caixin Online) -- China UnionPay Co.
Sign-up for Apple Pay to invade China, with help from UnionPay investment picks
The coal-fired Cholla Power Plant in Joseph City, Ariz., will close its 260-megawatt Unit 2 by April 2016 and stop burning coal at the other APS-owned units (1 and 3) by the mid-2020s if the U.S. Environmental Protection Agency (EPA) approves a compromise proposal offered by APS, the plant’s owner.
Sign-up for APS Proposes Compromise for Cholla Power Plant investment picks
Clinical oncology expert joins as company advances late-stage clinical programs BOULDER, Colo.
Sign-up for Array BioPharma Appoints Victor Sandor, M.D., As Chief Medical Officer investment picks
SANTA MONICA, Calif.
Sign-up for Art Coppola To Appear On Bloomberg TV's "Market Makers" investment picks
Leading German media service provider deploys complete suite of Aspera high-speed file transfer, automation & collaboration solutions AMSTERDAM , Sept.
Sign-up for Aspera, an IBM Company, Powers Complex Digital Media Workflows for WDR mediagroup investment picks
1 st Detect, a subsidiary of Astrotech (Nasdaq:ASTC), announced today its breakthrough technology has reached a key milestone in the military’s test and evaluation process for Multi-Sample Identifier Detector (MSID) solutions, by being awarded one of the competitive prototype contracts for the Next Generation Chemical Detector (NGCD) program.
Sign-up for Astrotech’s (NASDAQ:ASTC) 1st Detect Awarded New Contract for Next Generation Chemical Detection Solution investment picks
2014/9/11
Genzyme , a Sanofi company (EURONEXT: SAN and NYSE: SNY), announced today positive interim results from the second year of the extension study of Lemtrada ™ (alemtuzumab) for multiple sclerosis.
Sign-up for At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies investment picks
For the third year in a row AT&T * sits atop the Progressive Policy Institute’s (PPI) roundup of U.S. Investment Heroes.
Sign-up for AT&T Earns Top Spot on PPI U.S. Investment Heroes Rankings for Third Straight Year investment picks
BURLINGTON, Massachusetts , September 11, 2014 /PRNewswire/ -- Attunity, Ltd.
Sign-up for Attunity to Participate in the 5th Annual Craig-Hallum Alpha Select Conference on September 18th investment picks
MENLO PARK, Calif., Sept.
Sign-up for Avalanche Biotechnologies, Inc. Reports Second Quarter 2014 Financial Results investment picks
http://media.marketwire.com/attachments/201409/275460_EVRYTHNGlogo.jpeg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1143874&ProfileId=051205&sourceType=1 MENTOR, OH and LONDON, UNITED KINGDOM --
Sign-up for Avery Dennison and EVRYTHNG to Make Products Smart investment picks
PARSIPPANY, N.J., and AUCKLAND, New Zealand, Sept.
Sign-up for Avis Voted #1 by New Zealand Travel Professionals investment picks
Aviva Investors, the global asset management business of Aviva plc, and Westwood Holdings Group, Inc. (NYSE:WHG), a U.S.-based global asset manager, today announced that they intend to enter into an agreement for Westwood to sub-advise the Aviva Investors Global Convertibles Absolute Return Fund.
Sign-up for Aviva Investors announces Global Convertibles Absolute Return Sub-Advisory Agreement with Westwood Holdings Group investment picks
"INformation QUality and Identity Resolution Engine" SDK complements biometric search with text-based filter, search, match, and link algorithms BEDFORD, Mass.
Sign-up for Aware Introduces INQUIRE™ Software for Text-Based Identity Data Management and Analytics investment picks
Second Chipmaker to Install the Complete Purion Platform to Leverage Industry's Most Innovative Implant Technology Across the Full Applications Space BEVERLY, Mass.
Sign-up for Axcelis Ships The Second 'Purion H' High Current Implanter To Leading Chipmaker In Asia Pacific Region investment picks
BROOMFIELD, Colo.
Sign-up for Ball Reaffirms Leadership Position on Dow Jones Sustainability Index investment picks
2014/9/11
NEW YORK , Sept.
Sign-up for Bankrate: Mortgage Rates Rise Slightly investment picks
2014/9/11
Bellatrix provides an operational update Canada NewsWire TSX, NYSE MKT: BXE CALGARY , Sept.
Sign-up for Bellatrix provides an operational update investment picks
2014/9/11
TSX, NYSE MKT: BXE CALGARY , Sept.
Sign-up for Bellatrix provides an operational update investment picks
Ben Franklin Financial, Inc. (the “Company”) (OTCBB: BFFI), the holding company for Ben Franklin Bank (the “Bank”), announced today that the Board of Directors of the Company, together with the Board of Directors of Ben Franklin Financial, MHC (the “MHC”), has unanimously adopted a Plan of Conversion and Reorganization pursuant to which the Bank will reorganize from the two-tier mutual holding company structure to the stock holding company structure and will undertake a “second-step” stock offering of shares of common stock of a new holding company formed in connection with the conversion.
Sign-up for Ben Franklin Financial, Inc. Announces Plan To Implement Second Step Stock Conversion investment picks
BioTime, Inc. (NYSE MKT: BTX) announced that its subsidiary Asterias Biotherapeutics, Inc. (OTCBB: ASTY) has reached an agreement with Cancer Research UK and Cancer Research Technology (CRT), the charity’s development and commercialization arm, to conduct a clinical trial of Asterias’ novel immunotherapy treatment AST-VAC2 in subjects with non-small cell lung cancer.
Sign-up for BioTime Subsidiary, Asterias Biotherapeutics, and Cancer Research UK and Cancer Research Technology Partner for Clinical Trial of Immunotherapy Vaccine for Lung Cancer investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Ameren Executives to Present at Wolfe Research Power & Gas Leaders Conference on Sept. 18, 2014 to BioTime Subsidiary, Asterias Biotherapeutics, and Cancer Research UK and Cancer Research Technology Partner for Clinical Trial of Immunotherapy Vaccine for Lung Cancer
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent